Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Urologix Inc Issues FY 2014 Revenue Guidance

Tuesday, 20 Aug 2013 04:00pm EDT 

Urologix Inc announced that for fiscal 2014, it expects total revenue guidance range of $15 million to $17 million. 

Company Quote

0.014 +8.27%
11 Jul 2014